Literature DB >> 6323208

Histological classification and histogenesis of lung cancer.

K M Müller.   

Abstract

This article includes a summary on the present state of histological classifications and histogenetic aspects of malignant lung tumours. The development of histological classifications during the past 50 years is presented in brief retrospect. Based on the 1981 WHO classification, such frequent histological tumour types as squamous cell carcinomas, small cell carcinomas, different types of adenocarcinomas, and large cell carcinomas, are discussed with the aid of selected microphotographs. Histochemical and electronoptical findings are considered. Discussed in particular are the difficulties of a uniform histological grading, as well as the frequency and categorization of combined tumour types. The consideration of histogenetic aspects is supported by morphological and epidemiological findings, and the results of animal experiment on preneoplastic mucosal lesions. DNA measurements on the heterogeneity and polyclonality of tumours are discussed in light of recent developments.

Entities:  

Mesh:

Year:  1984        PMID: 6323208

Source DB:  PubMed          Journal:  Eur J Respir Dis        ISSN: 0106-4339


  3 in total

Review 1.  Cross-talk between lung cancer and bones results in neutrophils that promote tumor progression.

Authors:  Patrick O Azevedo; Ana E Paiva; Gabryella S P Santos; Luiza Lousado; Julia P Andreotti; Isadora F G Sena; Carlos A Tagliati; Akiva Mintz; Alexander Birbrair
Journal:  Cancer Metastasis Rev       Date:  2018-12       Impact factor: 9.264

2.  Cyclic adenosine monophosphate-dependent cell type-specific modulation of mitogenic signaling by retinoids in normal and neoplastic lung cells.

Authors:  Hussein A N Al-Wadei; Hildegard M Schuller
Journal:  Cancer Detect Prev       Date:  2006-10-25

Review 3.  Current and Prospective Protein Biomarkers of Lung Cancer.

Authors:  Tatiana N Zamay; Galina S Zamay; Olga S Kolovskaya; Ruslan A Zukov; Marina M Petrova; Ana Gargaun; Maxim V Berezovski; Anna S Kichkailo
Journal:  Cancers (Basel)       Date:  2017-11-13       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.